Gwangmyeong-si, South Korea

Sang Soo Bang


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2011

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Sang Soo Bang: Innovator in TRPV2 Activation Screening

Introduction

Sang Soo Bang is a notable inventor based in Gwangmyeong-si, South Korea. He has made significant contributions to the field of medical research, particularly in the area of pain management and sensory neuron studies.

Latest Patents

Sang Soo Bang holds a patent for "Methods for screening for inhibitors of TRPV2 activation." This invention relates to a method for activating TRPV2 (transient receptor potential vanilloid 2) using probenecid. More specifically, it provides a method for selecting a candidate for a TRPV2 blocker using probenecid. The probenecid described in this patent works specifically on TRPV2, facilitating the isolation of sensory neurons that express TRPV2. This innovation can be effectively utilized for studies on TRPV2 mechanisms and the development of TRPV2-based analgesics.

Career Highlights

Sang Soo Bang is affiliated with the Korea University Industry and Academic Collaboration Foundation. His work there emphasizes the intersection of academic research and practical applications in the medical field.

Collaborations

Sang Soo Bang has collaborated with notable colleagues, including Sun Wook Hwang and Sang Heon Lee. Their combined expertise contributes to advancements in their respective research areas.

Conclusion

Sang Soo Bang's innovative work in TRPV2 activation screening represents a significant step forward in pain management research. His contributions are poised to impact the development of new therapeutic options for patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…